← All trials

NCT04643457

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 31, 2020
Primary completion
Jan 31, 2023
Completion date
Jan 31, 2023
First posted
Nov 25, 2020
Last posted
Dec 3, 2020
Enrollment
159
Arms / groups
11 / —
Source
AACT · ingestion pipeline

Sponsors

  • UCBLead sponsor
  • UCBStudy director

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.